Exam 47: Benign Prostatic Hypertrophy

Your 60-year-old male patient has just been diagnosed by you with benign prostatic hyperplasia. He states he wants a transurethral resection of the prostate, because that's what his brother had "and it took care of the problem right away." You provide him with appropriate education regarding his treatment options, but he continues to insist on invasive treatment. It would be most appropriate to:

More recent studies have indicated that ___________ and _____________ increase the risk of BPH and BPH symptom progression.

Per the warnings of the Food and Drug Administration, it is important to insure that your patient's ophthalmologist is aware that your patient is taking an α₁-blocker because the medication puts the patient at risk for:

With respect to the prevalence and incidence of benign prostatic hyperplasia, which of the following statements is true?

You have just diagnosed your patient with benign prostatic hyperplasia. He has an AUA Symptom Index score of 18. You discuss starting pharmacotherapy with your patient and he states that he has heard that saw palmetto is a safe and effective wonder-drug from his herbalist friend and so he wants to treat his symptoms with saw palmetto. Your evidence-based therapeutic response would be:

There is a clear correlation between the development of BPH and getting prostatic cancer.

Which of the following statements is not true?

Your 50-year-old male patient comes to the clinic with a complaint of hesitancy during voiding. After completing an appropriate history and physical, you diagnose him with benign prostatic hyperplasia. His American Urological Association (AUA) Symptom Index Score is less than seven. Your initial treatment plan should include:

Appropriate screening tests for benign prostatic hyperplasia (BPH) include:

Goals of clinical management of benign prostate hyperplasia include:

The size of the prostate, as determined during the digital rectal exam, can be expected to correlate with the severity of the symptoms of benign prostatic hyperplasia.